ABSTRACT
Recently, a dual-wavelength 532/940-nm laser has become available for treatment of
facial vascular lesions as an alternative to the flashlamp pumped-dye lasers. Most
facial vascular lesions will respond to the 532-nm wavelength. However, some of the
larger and deeper lesions are resistant to this laser. The 940-nm wavelength can be
used to treat these resistant lesions. Sixteen patients with 532-nm laser-resistant
vascular lesions were treated with the 940-nm laser. Fourteen of these 16 patients
had improvement in their telangiectasia in response to these treatments. Most facial
l telangiectasias respond well to treatment with the 532-nm laser. However, some of
the larger and deeper lesions will not respond well to this laser. The 940-nm wavelength
laser can be used to treat these 532-nm laser resistant lesions.
KEYWORDS
Vascular laser - telangectasias - 532/940-nm laser - vasular lesions
REFERENCES
- 1
Broska P, Martinho E, Goodman M M.
Comparison of the argon tunable dye laser with the flashlamp pulsed dye laser in treatment
of facial telangiectasia.
J Dermatol Surg Oncol.
1994;
20
749-753
- 2
Cassuto D, Ancona D, Emanuelli G.
Treatment of facial telangiectasias with a diode-pumped Nd:YAG laser at 532 nm.
J Cutan Laser Ther.
2000;
2
141-146
- 3
Shamma A R, Ramadan F M, Vonderlieth K.
Transdermal laser treatment of facial telangiectasia-comparison of the 532 nm KTP
to the 940 nm diode wavelength. Proceedings of the International Vein Congress.
2004;
- 4
Kauvar A NB, Fre K E, Friedman P M, Geronemus R G.
Cooling gel improves pulsed KTP laser treatment of facial telangiectasia.
Lasers Surg Med.
2002;
30
149-153
Paul J CarniolM.D. F.A.C.S.
33 Overlook Road, Suite 401, Summit, NJ 07901